Skip to content [s] Site map [3] Home [1]
Graphic text

Cancer Research and Foundation News

Trial shows Zyprexa controls Chemo nausea

May 29, 2012

In a phase III clinical trial, the antipsychotic drug olanzapine (Zyprexa) was significantly more effective than metoclopramide (Reglan) in controlling chemotherapy-induced nausea and vomiting that occurs in some patients despite preventive treatment for these side effects.

Gift Acknowlegement Critical to Deduction

May 24, 2012

Failure of gift acknowledgement to specify donors received no benefit costs Texas couple $9K in tax + penalty

Pancreatic Cancer Detected with Simple Intestinal Probe

May 22, 2012

By simply shining a tiny light within the small intestine, close to that organ’s junction with the pancreas, physicians at the Mayo Clinic have been able to detect pancreatic cancer 100 percent of the time in a small study. The minimally invasive technique, called Polarization Gating Spectroscopy, will now be tested in a much larger international clinical trial. The preliminary study suggests it may be possible, one day, to use a less invasive endoscope to screen patients for early development of pancreatic cancer.

Share this Page

Stay Connected

Button Button Button Button

Get Hope!

Sign up for our newsletter and updates.

CHRISTUS Stehlin Foundation for Cancer Research

10301 Stella Link Road, Suite A
Houston, Texas 77025-5447

Affiliates and Resources

Logo Logo Logo Logo Logo